208 related articles for article (PubMed ID: 19069312)
1. Cyclooxygenase-2 inhibitors and antioxidants in the treatment of cachexia.
Mantovani G; Madeddu C
Curr Opin Support Palliat Care; 2008 Dec; 2(4):275-81. PubMed ID: 19069312
[TBL] [Abstract][Full Text] [Related]
2. Cachexia and oxidative stress in cancer: an innovative therapeutic management.
Mantovani G; Madeddu C; Macciò A
Curr Pharm Des; 2012; 18(31):4813-8. PubMed ID: 22632861
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress and wasting in cancer.
Laviano A; Meguid MM; Preziosa I; Rossi Fanelli F
Curr Opin Clin Nutr Metab Care; 2007 Jul; 10(4):449-56. PubMed ID: 17563463
[TBL] [Abstract][Full Text] [Related]
4. Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia.
Mantovani G; Macciò A; Madeddu C; Serpe R; Antoni G; Massa E; Dessì M; Panzone F
J Mol Med (Berl); 2010 Jan; 88(1):85-92. PubMed ID: 19802504
[TBL] [Abstract][Full Text] [Related]
5. Cancer-related anorexia/cachexia syndrome and oxidative stress: an innovative approach beyond current treatment.
Mantovani G; Madeddu C; Macciò A; Gramignano G; Lusso MR; Massa E; Astara G; Serpe R
Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1651-9. PubMed ID: 15466983
[TBL] [Abstract][Full Text] [Related]
6. Systemic inflammation, cachexia and prognosis in patients with cancer.
Deans C; Wigmore SJ
Curr Opin Clin Nutr Metab Care; 2005 May; 8(3):265-9. PubMed ID: 15809528
[TBL] [Abstract][Full Text] [Related]
7. Non-steroidal anti-inflammatory drugs for the treatment of cancer cachexia: a systematic review.
Reid J; Hughes CM; Murray LJ; Parsons C; Cantwell MM
Palliat Med; 2013 Apr; 27(4):295-303. PubMed ID: 22450159
[TBL] [Abstract][Full Text] [Related]
8. Current pharmacotherapy options for cancer anorexia and cachexia.
Macciò A; Madeddu C; Mantovani G
Expert Opin Pharmacother; 2012 Dec; 13(17):2453-72. PubMed ID: 23072481
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulatory agents for the treatment of cachexia.
Chasen M; Bhargava R; Hirschman S
Curr Opin Support Palliat Care; 2014 Dec; 8(4):328-33. PubMed ID: 25111255
[TBL] [Abstract][Full Text] [Related]
10. An update on promising agents for the treatment of cancer cachexia.
Madeddu C; Mantovani G
Curr Opin Support Palliat Care; 2009 Dec; 3(4):258-62. PubMed ID: 19667995
[TBL] [Abstract][Full Text] [Related]
11. Multitargeted treatment of cancer cachexia.
Madeddu C; Maccio A; Mantovani G
Crit Rev Oncog; 2012; 17(3):305-14. PubMed ID: 22831161
[TBL] [Abstract][Full Text] [Related]
12. The therapeutic potential of exercise to treat cachexia.
Lira FS; Antunes Bde M; Seelaender M; Rosa Neto JC
Curr Opin Support Palliat Care; 2015 Dec; 9(4):317-24. PubMed ID: 26509857
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological management of cachexia in adult cancer patients: a systematic review of clinical trials.
Advani SM; Advani PG; VonVille HM; Jafri SH
BMC Cancer; 2018 Nov; 18(1):1174. PubMed ID: 30482179
[TBL] [Abstract][Full Text] [Related]
14. On our way to targeted therapy for cachexia in cancer?
Boddaert MS; Gerritsen WR; Pinedo HM
Curr Opin Oncol; 2006 Jul; 18(4):335-40. PubMed ID: 16721127
[TBL] [Abstract][Full Text] [Related]
15. A phase II study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anti-cyclooxygenase-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia and oxidative stress.
Mantovani G; Macciò A; Madeddu C; Gramignano G; Lusso MR; Serpe R; Massa E; Astara G; Deiana L
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):1030-4. PubMed ID: 16702388
[TBL] [Abstract][Full Text] [Related]
16. Editorial update on emerging drugs for cancer cachexia.
Murphy KT; Lynch GS
Expert Opin Emerg Drugs; 2012 Mar; 17(1):5-9. PubMed ID: 22229463
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients: assessment of the most important laboratory indexes of cachexia and oxidative stress.
Mantovani G; Macciò A; Madeddu C; Mura L; Gramignano G; Lusso MR; Massa E; Mocci M; Serpe R
J Mol Med (Berl); 2003 Oct; 81(10):664-73. PubMed ID: 12928788
[TBL] [Abstract][Full Text] [Related]
18. Molecular Pathways: Cachexia Signaling-A Targeted Approach to Cancer Treatment.
Miyamoto Y; Hanna DL; Zhang W; Baba H; Lenz HJ
Clin Cancer Res; 2016 Aug; 22(16):3999-4004. PubMed ID: 27340276
[TBL] [Abstract][Full Text] [Related]
19. Celecoxib attenuates cachectic events in mice by modulating the expression of vascular endothelial growth factor.
Xu X; Jiang M; Zhang Y; Bi Y; Han M
Mol Med Rep; 2015 Jan; 11(1):289-94. PubMed ID: 25333891
[TBL] [Abstract][Full Text] [Related]
20. Rethinking nutritional support for persons with cancer cachexia.
McCarthy DO
Biol Res Nurs; 2003 Jul; 5(1):3-17. PubMed ID: 12886666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
